key: cord-1012964-lf5uu2l1
authors: Millar, Michael R.; Gourtsoyannis, Yannis; Jayakumar, Angelina
title: Ethics of vaccination: Should capability measures be used to inform SARS‐CoV‐2 vaccination strategies?
date: 2021-05-07
journal: Br J Clin Pharmacol
DOI: 10.1111/bcp.14875
sha: 794f825f57c3321f026a8674211d4f466febfb13
doc_id: 1012964
cord_uid: lf5uu2l1

Proposals for SARS‐CoV‐2 virus vaccination priorities in the UK and in many other countries are heavily influenced by epidemiological models, which use outcome measures such as deaths or hospitalisation. Limiting the values under consideration to those attributable to the direct effects of infection has the advantage of simplifying the models and the process of decision‐making. However, the consequences of the pandemic extend beyond outcomes directly attributable to SARS‐CoV‐2 infection, and include restrictions on educational and work opportunities, access to services, recreational activities, affiliations and relationships with others, freedom of movement (including escaping abusive relationships), and other determinants of human experience. Capability theory gives emphasis to the freedoms that individuals have to express themselves (in doings and beings). Restrictions on freedoms restrict our capabilities. Capability theory has been used to provide a framework for the evaluation and comparison of international development approaches and in the evaluation of public health policy. There is a clustering of disadvantages associated with this pandemic that adds to pre‐existing inequalities. Much of the disadvantage engendered in the SARS‐CoV‐2 pandemic is left out when public health policy is based on a limited range of metrics. Acknowledging the impact of policy across the range of human freedoms at both a national and international level has the potential to improve policy, facilitate the mitigation of direct and indirect adverse consequences, and improve public confidence and the effectiveness of vaccine deployment strategies.

Justice and fairness become issues when interests conflict. Not everyone can be vaccinated immediately. In the long term, it is in the interests of all that disease caused by SARS-CoV-2 virus is controlled.

In the short term, there are conflicts of interest entailed with distributing vaccines. The early distribution of the vaccine will potentially impact life expectancy, quality of life, risk, opportunity, security (financial and personal), and wellbeing of individuals unequally. Deciding on a fair distribution of a limited and potentially life-saving resource requires that we balance benefits and burdens. Whether individuals are happy to comply with the vaccination strategy will depend on the reasons given to support that strategy, the underlying principles and values used to justify priorities, and the sensitivity of vaccination programmes to local context. Operation Warp Speed in the USA 4 prioritised vaccination in the USA (America First). By contrast a World Health Organisation (WHO) proposal is that the vaccine should be distributed globally so that initially all countries would receive enough vaccine to immunise 3% of the population. 5 Emmanuel et al. 6 provide an ethical framework for global vaccine allocation focusing on 3 values. These are benefiting people and limiting harm, prioritising the disadvantaged, and giving an equal degree of moral concern to each person. Metrics are proposed that reflect these values and these include the standard expected years of life lost that can be averted by use of the vaccine (SEYLL). Vaccines should be distributed in order of priority to: (i) countries in which the vaccine would reduce more SEYLL per dose; (ii) countries that would reduce more poverty, avert more loss of gross national income and avert more SEYLL per dose; and (iii) to countries with higher transmission rates.

The WHO has proposed an overarching goal, which is that COVID-19 vaccines contribute significantly to the equitable protection and promotion of human well-being among all people of the world. The underlying values are human well-being, equal respect, global equity, national equity, reciprocity and legitimacy. 5 Human well-being requires priority to the reduction of deaths and disease burden from the COVID-19 pandemic, reduction of societal and economic disruption (other than through reducing deaths and disease burden), and the protection of the functioning of essential services, including health services. Equal respect requires that the interests of all individuals and groups are treated with equal consideration as allocation and priority-setting decisions are being taken and implemented, and that there is a meaningful opportunity to be vaccinated for all individuals and groups who qualify under prioritisation criteria.

National equity requires that countries take into account the vulnerabilities, risks and needs of groups who, because of underlying societal, geographic or biomedical factors, are at risk of experiencing greater burdens from the COVID-19 pandemic, and that countries take proactive action to ensure equal access to everyone who qualifies under a priority group, particularly socially disadvantaged populations. Priorities depend on national considerations, for example health workers in contexts with high levels of transmission would be given a high priority for vaccination.

The US National Academy of Sciences 7 suggests a primary goal of maximising societal benefit by reducing morbidity and mortality caused by transmission of SARS-CoV-2, while also mitigating health inequities, ensuring individuals are shown equal regard and fairness, and that policies are evidence-based and transparent. As with the WHO framework, the maintenance of health and emergency services is given a high priority in the early phase of vaccination in order to assure the maintenance of health and emergency services to aid prevention of morbidity and mortality.

The German Ethics council, Standing Committee on Vaccination, and the National Academy of Sciences Leopoldina joint position paper 8 identifies 3 priority groups. These groups are those at a high risk of death and serious illness due to their age, those who assist COVID-19 in the course of their work (such as health and care workers who are both at increased personal risk and may also be responsible for multiplier effects), and those who perform roles in services of general interest and that maintain central state functions. This paper invokes a number of ethical principles, including that of solidarity (the responsibility of those who are less at risk to temporarily put aside their own health protection, for the needs of those who are more at risk). Secondly, prioritising those individuals (such as essential workers) who provide instrumental value to society is consistent with the principle of reciprocity: recognising the additional personal risks and burdens assumed by keyworkers to maintain critical services for the benefit of society. By broadening this category to include service workers of general interest (such as supermarket staff and transportation workers), with some proposals extending this consideration to families of such workers, a form of recompense and reward for this service is put forward. Moreover, the reciprocity approach is linked to other relevant ethical objectives, such as advancing social equity.

The UK Joint Committee on Vaccination and Immunisation (JCVI) advises that "the first priorities for the COVID-19 vaccination programme should be the prevention of mortality and the maintenance of the health and social care systems. As the risk of mortality from COVID-19 increases with age, priorities are primarily based on age.

The order of priority for each group in the population corresponds with data on the number of individuals who would need to be vaccinated to prevent one death, estimated from UK data." 9 Quality adjusted life years (QALYs) are used as a health measure by the National Institute for Clinical Excellence in the UK. The JCVI also state that mathematical modelling suggests that prioritising by age will save more QALYs than alternative strategies. This is particularly important to acknowledge in the context of the common misconception that many elderly patients who die of COVID-19 die with COVID-19 rather than of COVID-19 or that they would imminently had died anyway regardless of COVID-19 infection. This is not the case. For example, those over the age of 80 years who contract COVID-19 have their lifespan curtailed by at least 2 years in the context of comorbidities and more than a decade in the absence of comorbidities. 10

Priorities based on a dominant metric such as lives saved, years of life saved, QALYs saved, SEYLL, societal benefit defined in terms of avoidable mortality and morbidity reflect what has been termed a monotheism of values. 11 The JCVI advice is largely based on epidemiology and mathematical modelling, and as such has attracted adverse criticism from ethicists. Giubilini et al. 11 argue that even when we accept that limited resources should be used to save the greatest number, and that the models are truly predictive, questions still remain with respect to the valuation placed on individual lives, and their quality. If the dominant principle is preventing loss of years of life, that would give different priorities to a principle based on preventing any death. SARS-CoV-2 is likely to be endemic in the world for many years to come. There are many uncertainties associated with modelling, which should give rise to concerns about the use of models as a sufficient basis for the design of policy. In addition, there are profound philosophical issues such as the weight that should be given to saving lives in the future. Insufficient consideration of global (as opposed to local) lives raises substantive moral questions and overlooks a continuing threat from new variants.

We accept some risks, even the risk of death, because the benefits are considered to outweigh the risks. For example, car driving is an accepted risk despite road traffic deaths. A risk may or may not become a reality at some time in the future. If death is the substantial concern, then we have to decide over what time period do we consider risk of death, and within which geographical boundaries? Lives can be saved but the question will always be at what cost and for whom? If we are to discount adverse effects in the future, then by how much? Children will bear burdens into the future as a consequence of this pandemic. The impact on children is discussed further on in this paper.

For many of the more disadvantaged, the risks of SARS-CoV-2 are death and multiple other risks. It is those multiple other risks which we should not forget about when formulating vaccination programmes. Several of the proposals for vaccination priorities refer to other considerations such as the importance of health equity, even so, death and disease remain a dominant metric. By contrast Schmidt 12 argues that in a US context, "Ethical, epidemiological, and economic reasons demand that rationing approaches give priority to groups who have been structurally and historically disadvantaged, even if this means that overall life years gained may be lower." He argues that essential workers (for example cleaners, supermarket workers, healthcare workers) should be given priority particularly when there is evidence of a heightened risk of infection and transmission associated with their roles. Schmidt draws attention to the fact that many of these essential workers come from deprived groups, adding to pragmatic arguments that emphasise the importance of maintaining essential services. Beyond these groups, he argues that, "When it comes to allocating vaccines among the general population, economic, ethical, and epidemiological considerations urge us to prioritise the worse off." For Schmidt, "reverting to 'color blind' allocation models-ones that ignore the pandemic's vastly disparate impact, especially on worse-off minorities-would be to risk becoming complicit in structures that, once again, systematically disadvantage worse-off populations."

It is clearly important to consider the policies that will save the most lives, but this is insufficient as a standalone principle when it comes to the SARS-CoV-2 pandemic. Utilitarianism is the theory that we should try to maximise the overall good (utility). "Utilitarianism is highly dependent on accurate information about the world. It requires good evidence. Without good evidence, it is less likely that we would choose means that will bring about the most good." 13 A substantive criticism of utilitarianism is that it does not specifically take account of the fairness of actions. The overall good may take little account of individual circumstances and the structural determinants of health driven by profoundly embedded racial, ethnic, and socioeconomic inequalities. Even if we accept some form of utilitarianism, we still have to be able to describe the good. Accurate information about the pandemic requires that we look beyond saving lives. The pandemic has widened disadvantage. Excess deaths are higher amongst disadvantaged households and have added other burdens to pre-existing inequalities. [14] [15] [16] [17] [18] There is a clustering of disadvantage associated with this pandemic. For example, children from disadvantaged backgrounds have suffered disproportionately as a result of the restrictions. 19 There is also evidence that systematic disadvantage is a factor in determining a reluctance to take up vaccination. [20] [21] [22] Attending to the intersection of these inequalities when making policy, whilst complex, is a key step in mitigating systematic disadvantages. 

A theoretical framework that focuses on human freedoms and inequalities is that derived from the work of Sen, Nussbaum, and others (for an overview see 27 ) . Capabilities are the opportunities that people have to achieve doings and beings (functionings), and as such are a measure of human wellbeing. Capability theory emphasises the freedoms that individuals have to express themselves. Every person is morally entitled to some level of a range of capabilities. Restrictions on freedoms restrict our capabilities. Capability theory has been used to provide a framework for the evaluation and comparison of international development 28 and in the evaluation and justification of public health policy. 29 Nussbaum has proposed a list of 10 capabilities required (at some minimal level) for each to live a life with human dignity. 30 38 Several papers have considered the application of capability theory in a UK context. [39] [40] [41] These reports suggest that a capabilities approach can be used to identify individuals and groups at substantial risk, particularly those at risk of a clustering of disadvantage.

Emanuel et al. 6 prioritise 3 values. These are benefiting people and limiting harm, prioritising the disadvantaged, and equal moral concern. With respect to disadvantage, they state that "Fairly distributing a COVID-19 vaccine internationally therefore requires assessing different types of disadvantage." Disadvantage is included in Phase 2 of the proposal suggested by Emanuel et al. 6 

High levels of vaccination-induced immunity will allow many freedoms otherwise curtailed by the risks of infection, so a capabilities approach does not preclude either mandatory vaccination, or incentives for vaccination. Antivaccine movements and outright scepticism are a real and increasing problem. 46 Vaccine hesitancy amongst historically disadvantaged and socially excluded groups 20 is a more significant problem in relative terms than ideologically driven scepticism. It has been argued that, for the foreseeable future at least, that vaccine demand will outstrip supply: "making the salient question not who must get them but who will be granted access to them." 47 The possibility that vaccine scepticism and hesitancy will not be the main rate-limiting factor is 1 reason why mandatory vaccination (which has been mooted in some quarters) may not be an appropriate component of a successful and equitable vaccination programme. It is also worth noting that penalties for vaccine-refusers have been trialled or considered in various settings abroad. These penalties have included: restriction of school access, 48 withholding of child benefit payments 49 and even employers taking on the right to refuse employment 50,51 to those who are unvaccinated. Not only do these penalties have a distinctly regressive, class-discriminatory character but the evidence for the actual effectiveness of mandating vaccine (assuming a plentiful supply) is mixed; whilst it may have an effect on vaccine uptake overall it has little to no effect on those who are of a genuinely antivaccination persuasion. 46 If we take children as an example, the impact of the pandemic on children will have profound effects into the future even when educational losses alone are considered. 54 Dixon & Nussbaum 55 have suggested that capability theory justifies a degree of priority for children's rights-based on the "unique vulnerability of children to the decisions of others" (p. 575). Nussbaum argues that capabilities are incommensurable. A policy that results in a substantial loss of a capability for some can be challenged from a capability perspective, even if there was an overall benefit. Policies which do not take adequate account of childhood capabilities should be questioned. For many disadvantaged groups the heightened risk of death co-exists with the many other risks that are alluded to in the British Academy report.

The State of Child Health Report 2020 56 published by the UK Royal College of Paediatrics and Child Heath shows high levels of child poverty, preventable adverse health outcomes, suboptimal vaccination rates, and youth violence. The education and mental health of children has been set back further by the pandemic, particularly for those children already disadvantaged. The risk of death from SARS-CoV-2 is low for children, while some will live in a disadvantaged family with others for whom the risk of death is higher. A multigenerational family with adults carrying out poorly paid essential public service jobs, with young children, and with insecure overcrowded accommodation carries multiple risks exacerbated by the pandemic. To quote from the British Academy report, 52 "It is not just the immediate mental health impacts on children and young people that should be of concern, but the problems that are being stored up for their future wellbeing." If childhood capabilities are to be assured, we need to use mitigation measures in ways which minimise the additional burdens imposed by the pandemic. A recent Save the Children study describes the adverse impact of the pandemic on children's health, nutrition, housing, education, sanitation, water, learning, protection, wellbeing and family finances, in addition to poverty. 57 Wang et al. 67 take existing ethical frameworks (including 5,6 mentioned above) to estimate vaccine target population sizes if 3 objectives are to be achieved. These objectives are: (i) to maintain core societal functions; (ii) to minimise deaths; and (iii) to reduce transmission. They add that "'additional factors such as availability of vaccines for initial distribution, epidemiological situation, and vaccine hesitancy should be taken into account by individual countries to refine allocation plans." They report substantial variations in numbers of essential workers and vulnerable populations in different regions: 2.2 billion people (27.7% of the global population) were found to be in a particularly vulnerable group, illustrating a substantial gap between projected COVAX objectives and vaccine need. Inevitably, there is currently competition for SARS-CoV-2 vaccines. The COVAX initiative is unlikely to be successful without substantial commitments from higher income countries. Even if COVAX achieves the target of 2 billion doses in 2021 that will still be grossly insufficient to achieve global herd immunity. 68 Higher income countries have blocked a proposal put to the World Trade Organisation by India and South Africa to waive intellectual property protections around vaccinations, which would have given lower income countries the freedom to manufacture and distribute vaccinations for a lower cost at the national level. 69 Vaccine distribution acts as a locus of tension between national self-interest and global justice concerns. The term vaccine sovereignty has been used to denote how access to vaccines are shaped by a nation's wealth and power, and how nonstate actors (pharmaceutical companies and research universities benefitting from public funding) reinforce these entrenched power imbalances between low and/or middle-income countries and high-income countries. 70 SARS-CoV-2 does not respect national boundaries. Control requires international cooperation and that requires some commonality of approach. Capability theory offers the potential of a common approach to vaccination policy that can extend across national boundaries. There are existing precedents for the use of capability measures. It may even be possible to modify existing capability measures such as the UN HDI to take account of the impact of SARS-CoV-2 and allow international comparisons. At the very least, capability theory offers a common set of dimensions to be taken into consideration in the development and implementation of policy.

Important dimensions of human experience that have been severely compromised by the SARS-CoV-2 epidemic are not well-captured when emphasis in policy making is based on the output of mathematical models in which death and disease are the dominant metrics.

Freedom from the burdens of SARS-CoV-2 can be better represented when we use metrics that capture relevant freedoms. Capability theory offers the potential for a better society, 71 in addition to offering the potential for a fairer and more effective approach to vaccination.

Draft landscape of COVID-19 candidate vaccines. World Health Organisation

Justice as Fairness: A Restatement

United States Department of Health and Human Services

WHO SAGE Roadmap for Prioritizing uses Of COVID-19 Vaccines In The Context Of Limited Supply. World Health Organisation

An ethical framework for global vaccine allocation

Discussion Draft of the Preliminary Framework for Equitable Allocation of COVID-19 Vaccine

the German Ethics Council and the National Academy of Sciences Leopoldina. Recommendations for fair and regulated access to a COVID-19 vaccine

19-vaccination-advice -from-the-jcvi-30-december-2020/joint-committee-on-vaccinationand-immunisation-advice-on-priority-groups-for-covid-19-vaccination-30-december-2020#vaccine-priority-groups-advice-on

COVID-19 -exploring the implications of long-term condition type and extent of multimorbidity on years of life lost: a modelling study

Vaccine distribution ethics: monotheism or polytheism

Covid-19: how to prioritize worse-off populations in allocating safe and effective vaccines

Utilitarianism and the pandemic

Factors associated with COVID-19-related death using OpenSAFELY

COVID-19) related deaths by ethnic group, England and Wales -Office for National Statistics

A population-based cohort study of socio-demographic risk factors for COVID-19 deaths in Sweden

COVID-19) related deaths by occupation, before and during lockdown, England and Wales -Office for National Statistics

Deaths involving COVID-19 by local area and socioeconomic deprivation -Office for National Statistics

A Right to Care: The Social Foundations of Recovery from Covid-19. London: LSE Monograph

Predictors of COVID-19 vaccine hesitancy in the UK Household Longitudinal Study. med-Rxiv Published online

London missed out on early share of vaccine. The Guardian Available at

Investigation into pre-school vaccinations -National Audit Office (NAO) Report. National Audit Office

COVID-19 as a Capability Crisis: Using the Capability Framework to Understand Policy Challenges

Updated estimates of the impact of COVID-19 on global poverty: Looking back at 2020 and the outlook for 2021

Office for National Statistics, UK government

Ethical Allocation of Future COVID-19 vaccines

The Capability Approach: An Interdisciplinary Introduction

United Nations Development Programme

Applications of the Capability Approach in the Health Field: A Literature Review

Frontiers of justice: disability, nationality, species membership

Human Capabilities and Pandemics

Operationalising the capability approach as an outcome measure in public health: The development of the OCAP-18

A Capability Perspective on Antibiotic Resistance, Inequality, and Child Development

Capability Instruments in Economic Evaluations of Health-Related Interventions

United Nations Human Development Index

Planetary pressures-adjusted Human Development Index

Gender Inequality and the COVID-19 Crisis: A Human Development Perspective

Non-monetary poverty and deprivation: a capability approach

Entitlements, capabilities, and crisis in the United Kingdom

Material poverty and multiple deprivation in Britain: the distinctiveness of multidimensional assessment

Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications

Covid À19 vaccine hesitancy among ethnic minority groups

Disadvantage indices can help achieve equitable vaccine allocation

Development, capabilities and freedom

Anti-vaccine movement could undermine efforts to end coronavirus pandemic, researchers warn

Determinants of COVID-19 Vaccine Acceptance in the U.S. medRxivPublished online

Ensuring Uptake of Vaccines against SARS-CoV-2

The case for mandatory vaccination

No jab, no pay": catch-up vaccination activity during its first two years

Pimlico Plumbers to make workers get vaccinations. BBC News

The Covid Decade: Understanding the longterm societal impacts of COVID-19

Shaping the COVID decade: Addressing the long-term societal impacts of COVID-19. London: The British Academy

The effect of college education on mortality

Children's Rights and a Capabilities Approach: The Question of Special Priority

Royal College of Paediatrics and Child Health Report

Available at https://resourcecentre. savethechildren.net/library/hidden-impact-covid-19-children-globalresearch-series

Drolet BC Multivalue ethical framework for fair global allocation of a COVID-19 vaccine

Global vaccine action plan: monitoring, evaluation and accountability. World Health Organisation

Centres for Disease Control and Prevention. New Covid-19 variants

COVAX: Working for global equitable access to COVID-19 vaccines

Independent Panel for Pandemic Preparedness and Response for the WHO Executive Board

Why a pioneering plan to distribute COVID vaccines equitably must succeed

The Launch and Scale Speedometer. Mapping Covid-19 vaccine purchases across the globe

Ethics and the Foundation of Global Justice

Global, regional, and national estimates of target population sizes for covid-19 vaccination: descriptive study

An African plan to control Covid-19 is urgently needed

At WTO, a battle for access to COVID-19 vaccines

Oxford, Astra-Zenecea deal reinforces vaccine sovereignty. We need a people's vaccine instead

Ethics of vaccination: Should capability measures be used to inform SARS-CoV-2 vaccination strategies?

The authors have not declared any conflict of interest.

This work was not funded.

https://orcid.org/0000-0002-5675-9679